BioSpace News Archive

Data from a new preclinical mouse study suggests a unique mechanism of CaPre compared to metformin and icosapent ethyl (VASCEPA®) in a diet-induced obesity animal model

In this study, researchers reported that administration of Tβ4 to animals with induced kidney injury significantly reduced ischemic acute kidney injury.

The parties have reached a partnership for two bispecific antibody programs.

The Company intends to assess the safety and efficacy of a repeated administration of the low dose of AstroRx® cells in Cohort C

The rise of immune-oncology and adoptive cell therapy is driving the boom of several biotech startup organizations that use the types of protocols and methods developed on Cellometer instruments by Nexcelom.

[18-November-2019] THOUSAND OAKS, Calif. , SOUTH SAN FRANCISCO, Calif. , and SURESNES, France, Nov. 18, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier announced that new results from COSMIC-HF ( C hronic O ral S tudy of M yosin Activation to I ncrease C ontractility in H eart F ailure), a Phase 2 trial evaluating omecamtiv mecarbil in pat

LabCorp® (NYSE: LH) announced today that it has commenced a cash tender offer (the Offer) to purchase up to $300,000,000 principal amount (the Tender Cap) of its outstanding $600,000,000 aggregate principal amount of 4.625% Senior Notes due 2020 (CUSIP No. 50540RAJ1) (the Notes).

Third quarter 2019 financial results conference call on Monday, November 25th at 1:30 p.m PT, 4:30 p.m. ET.

E-Commerce Site: www.taurigum.com

An intuitive, versatile platform optimized for the clinical pathology workflow